1. Home
  2. STELLA PHARMA NEWS
  3. Press Release
STELLA PHARMA NEWS
Press Release
Press Release BNCT
December 13th, 2023

Stella Pharma, Mitsubishi Chemical Group, and the University of Tokyo conclude Joint Research Agreement—Accelerating practical application of polyvinyl alcohol (PVA) for boron neutron capture therapy (BNCT)—

Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi C……

READ MORE

Press Release BNCT
June 24th, 2022

Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China

Sumitomo Heavy Industries, Ltd. and STELLA PHARMA CORPORATION have respectively……

READ MORE

Press Release
May 19th, 2020

STELLA PHARMA will launch Steboronine®, the World’s First BNCT Drug, on May 20, 2020

STELLA PHARMA CORPORATION (Head office: Chuoku, Osaka City; President: Tomoyuki……

READ MORE

Press Release
March 25th, 2020

STELLA PHARMA Receives Marketing and Manufacturing Approval in Japan for “Steboronine® Intravenous Drip Bag 9000mg/300mL

STELLA PHARMA CORPORATION (Head office: Chuo-ku, Osaka City, President: Tomoyuk……

READ MORE

Press Release
January 23rd, 2020

How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment

Boron neutron capture therapy (BNCT) is a technique in which p‐boronophenylalan……

READ MORE

Press Release
November 7th, 2019

“Commencement of Clinical Trial of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma and Angiosarcoma” issued

Cancer Intelligence Care Systems, Inc. (“CICS;” President: Tetsuya Furukawa; he……

READ MORE

Press Release
October 15th, 2019

STELLA PHARMA CORPORATION has recently filed for approval to manufacture and sell a boron agent for BNCT

STELLA PHARMA CORPORATION (Head office: Chuo-ku, Osaka City; President: Tomoyuk……

READ MORE

←123